Milestone Scientific Guides Q2 Revenue to $2.8M, Beating Views

Milestone Scientific (MLSS) said Tuesday it expects second-quarter revenue of $2.8 million, a 21% increase from a year earlier and above the consensus estimate of $2.6 million.

The dental technology company attributed the gain to higher sales of its CompuFlo and STA Single Tooth Anesthesia systems. The quarter ended June 30.

Milestone's guidance implies a sequential acceleration from the first quarter, when revenue totaled $2.4 million. The company has been pushing its computer-controlled injection systems into a dental market that has historically relied on manual syringes.

The $2.8 million figure is preliminary and subject to adjustment when Milestone files its full quarterly report. The company did not provide an earnings-per-share range or a gross margin estimate.

Shares of the Roseland, New Jersey-based company have traded below $1 for most of the past year. The stock closed at $0.48 on Monday, giving it a market capitalization of roughly $18 million. Milestone has not posted a profitable quarter since 2021.

The company's cash position stood at $2.1 million as of March 31, according to its first-quarter filing. Milestone said in May it had secured a $1.5 million credit line from its largest shareholder to fund operations through the second half of 2026.

Milestone plans to release full second-quarter results in mid-August.